Browse > Article
http://dx.doi.org/10.11620/IJOB.2017.42.1.033

Ursodeoxycholic Acid Inhibits Inflammatory Cytokine Expression in THP-1 Cells Infected with Aggregatibacter actinomycetemcomitans  

Song, YuRi (Department of Oral Microbiology, School of Dentistry, Pusan National University)
Kim, SeYeon (Department of Oral Microbiology, School of Dentistry, Pusan National University)
Park, Mee Hee (Department of Oral Microbiology, School of Dentistry, Pusan National University)
Na, Hee Sam (Department of Oral Microbiology, School of Dentistry, Pusan National University)
Chung, Jin (Department of Oral Microbiology, School of Dentistry, Pusan National University)
Publication Information
International Journal of Oral Biology / v.42, no.1, 2017 , pp. 33-38 More about this Journal
Abstract
Background: Periodontitis is an inflammatory disease characterized by the breakdown of tooth-supporting tissues, leading to tooth loss. Aggregatibacter actinomycetemcomitans are major etiologic bacterium causing aggressive periodontitis. Ursodeoxycholic acid (UDCA), a hydrophilic gall bladder acid, has been used as an effective drug for various diseases related to immunity. The aim of this study was to investigate the effect of UDCA on the inflammatory response induced by A. actinomycetemcomitans. Methods: A human acute monocytic leukemia cell line (THP-1) was differentiated to macrophage- like cells by treatment with phorbol 12-mystristate 13-acetate (PMA) and used for all experiments. The cytotoxic effect of UDCA was examined by MTT assay. THP-1 cells were pretreated with UDCA for 30 min before A. actinomycetemcomitans infection and the culture supernatant was analyzed for various cytokine production by ELISA. The effect of UDCA on bacterial growth was examined by measuring optical densities using a spectrophotometer. Results: UDCA showed no cytotoxic effect on THP-1 cells, up to $80{\mu}M$ Ed highlight: Please confirm technical meaning. UDCA pretreatment inhibited the A. actinomycetemcomitans-induced $IL-1{\beta}$, $TNF-{\alpha}$, and IL-17A secretion in a dose-dependent manner. UDCA also inhibited IL-21 production at $60{\mu}M$. The production of IL-12 and IL-4 was not influenced by A. actinomycetemcomitans infection. Conclusion: These findings indicate that UDCA inhibits the production of inflammatory cytokines involved in innate and Th17 immune responses in A. actinomycetemcomitans-infected THP-1- derived macrophages, which suggests its possible use for the control of aggressive periodontitis.
Keywords
A. actinomycetemcomitans; ursodeoxycholic acid; macrophage; $IL-1{\beta}$; $TNF-{\alpha}$; IL-17A; periodontitis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Prakasam, A., S.S. Elavarasu, and R.K. Natarajan, Antibiotics in the management of aggressive periodontitis. J Pharm Bioallied Sci, 2012;4:S252-5 doi:http://dx.doi.org/10.1902/jop.2005.76.2.289.   DOI
2 Gajardo, M., et al., Prevalence of periodontopathic bacteria in aggressive periodontitis patients in a Chilean population. J Periodontol, 2005;76(2):289-94 doi:http://dx.doi.org/ 10.1902/jop.2005.76.2.289.   DOI
3 Slots, J. and M. Ting, Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000, 1999;20:82-121.   DOI
4 Johansson, A., Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins (Basel), 2011;3(3): 242-59. doi:http://dx.doi.org/10.3390/toxins3030242.   DOI
5 Gursoy, U.K., Periodontal bacteria and epithelial cell interactions: role of bacterial proteins. Eur J Dent, 2008;2(4):231-2.
6 Tribble, G.D. and R.J. Lamont, Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000, 2010;52(1):68-83.   DOI
7 Park, E., et al., Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infect Immun, 2014;82(1):112-23.   DOI
8 Li, Y., et al., D(-)-Salicin inhibits the LPS-induced inflammation in RAW264.7 cells and mouse models. Int Immunopharmacol, 2015;26(2):286-94. doi:http://dx.doi.org/10.1016/j.intimp.2015.04.016   DOI
9 Tint, G.S., et al., Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med, 1982;97(3):351-6.   DOI
10 Joo, S.S., et al., Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1 beta and nitric oxide in rat microglia. Arch Pharm Res, 2006;26(12):1067-73.   DOI
11 Hajishengallis, G., Immune evasion strategies of Porphyromonas gingivalis. J Oral Biosci, 2011;53(3)233-240.
12 Kononen, E. and H.P. Muller, Microbiology of aggressive periodontitis. Periodontol 2000, 2014;65(1):46-78.   DOI
13 Kelk, P., et al., Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun, 2005;73(1):453-8.   DOI
14 Shenker, B.J., et al., Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun, 2015;83(4): 1487-96. doi:http://dx.doi.org/ 10.1128/IAI.03132-14.   DOI
15 Cekici, A., et al., Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000, 2014;64(1):57-80. doi:http://dx.doi.org/10.1111/prd.12002.   DOI
16 Dutzan, N., et al., Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol, 2012;83(7):948-54.   DOI
17 Arun, K.V., A. Talwar, and T.S. Kumar, T-helper cells in the etiopathogenesis of periodontal disease: A mini review. J Indian Soc Periodontol, 2011;15(1):4-10. doi:http://dx.doi.org/10.4103/0972-124x.82255   DOI
18 Zacarias, J.M., et al., The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients. Mediators Inflamm, 2015;2015:147056.
19 Takahashi, K., et al., The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol, 2005;32(4):369-74.   DOI
20 Park, S.-H., A Short-Term Study of the Effects of UDCA on Gingival Inflammation in the Beagle Dog. J Korean Acad Periodontol, 1999;1-14.
21 Sombetzki, M., et al., 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. J Hepatol, 2015; 62(4):871-8. doi: http://dx.doi.org/10.1016/j.jhep.2014.11.020.   DOI
22 Nguyen, L., et al., Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res, 1991;10(1-2):15-21.
23 Pang, L., et al., Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases. Nutrients, 2015;7(5):3200-18. doi:http://dx.doi.org/10.3390/nu7053200.   DOI